Allergic mechanisms involve the immune system's aberrant response to usually harmless substances, leading to allergic reactions. Sensitization occurs when an individual is exposed to an allergen, prompting the immune system to produce specific antibodies, mainly immunoglobulin E (IgE). Upon subsequent exposure to the same allergen, IgE antibodies trigger the release of various chemical mediators, such as histamine, from mast cells and basophils. Histamine and other mediators cause the characteristic symptoms of allergies, including itching, swelling, and inflammation. The process involves the activation of immune cells, particularly T-helper 2 (Th2) cells, which release cytokines that promote the production of IgE antibodies. Allergic reactions can manifest in various forms, such as allergic rhinitis, asthma, atopic dermatitis, and anaphylaxis. The genetic predisposition, environmental factors, and the type of allergen influence the development and severity of allergic responses. Understanding allergic mechanisms is crucial for diagnosis and treatment. Allergy testing, including skin tests and blood tests, helps identify specific allergens. Management strategies include allergen avoidance, pharmacotherapy with antihistamines and corticosteroids, and immunotherapy to modify the immune response. Ongoing research aims to uncover new insights into allergic mechanisms, paving the way for more targeted and effective allergy treatments.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States